Mingshan Niu
- Toxicology top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation 8
- NF-κB Signaling Pathways 6
- Genetics top 10%
- Hematology top 10%
- Acute Myeloid Leukemia Research 12
- Multiple Myeloma Research and Treatments 5
- Oncology top 10%
- Cancer-related Molecular Pathways 5
-
- Cell death mechanisms and regulation 7
- Ubiquitin and proteasome pathways 6
-
- Cancer Mechanisms and Therapy 5
- Cited by
- ToxicologyCancer ResearchGenetics
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Mingshan Niu
75 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 110
- Toxicology 60
- Cancer Research 249
- Genetics 158
- Hematology 148
- Oncology 335
Countries citing papers authored by Mingshan Niu
This map shows the geographic impact of Mingshan Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingshan Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingshan Niu more than expected).
Fields of papers citing papers by Mingshan Niu
This network shows the impact of papers produced by Mingshan Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingshan Niu. The network helps show where Mingshan Niu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingshan Niu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 18 | |
| 4 | 2022 | 7 | |
| 5 | 2020 | 24 | |
| 6 | 2020 | 21 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 6 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 16 | |
| 12 | 2018 | 16 | |
| 13 | 2016 | 8 | |
| 14 | 2015 | 40 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 29 | |
| 17 | 2015 | 17 | |
| 18 | 2015 | 33 | |
| 19 | 2015 | 38 | |
| 20 | 2014 | 24 |
About Mingshan Niu
Mingshan Niu is a scholar working on Hematology, Cancer Research and Toxicology, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), MicroRNA in disease regulation (8 papers), Cell death mechanisms and regulation (7 papers), Ubiquitin and proteasome pathways (6 papers), NF-κB Signaling Pathways (6 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer-related Molecular Pathways (5 papers) and Cancer Mechanisms and Therapy (5 papers). The work is most often cited by research in Toxicology (60 citations), Cancer Research (249 citations) and Genetics (158 citations). Mingshan Niu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xuejiao Liu, Kailin Xu, Lingyu Zeng, Rutong Yu, Shangfeng Gao, Jianlin Qiao, Sijin Wu, Huize Liu, Jiang Cao and Qingyun Wu. Their work appears in journals such as Blood, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.